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Foreword
As the largest organ of the body, the skin performs multiple critical functions, such as serving as the primary barrier to the external environment. For this reason, the skin is often exposed to potentially hazardous agents, including chemicals, which may contribute to the onset of a spectrum of adverse health effects ranging from localized damage (e.g., irritant contact dermatitis and corrosion) to induction o f immune-mediated responses (e.g., allergic contact dermatitis and pulmonary responses), or systemic toxicity (e.g., neurotoxicity and hepatoxicity). Understanding the hazards related to skin contact with chemicals is a critical component of modern occupational safety and health programs.
In  2009, the National Institute for Occupational Safety and H ealth (N IO SH ) pub­lished Current Intelligence Bulletin (CIB) 61: A  Strategy fo r  Assigning New N IO SH  Skin Notations [N IO S H  2009-147]. This document provides the scientific rationale and framework for the assignment o f multiple hazard-specific skin notations (SK) that clearly distinguish between the systemic effects, direct (localized) effects, and immune- mediated responses caused by skin contact with chemicals. The key step within assign­m ent o f the hazard-specific SK is the determination o f a substance’s hazard potential, or its potential for causing adverse health effects as a result o f skin exposure. This determ i­nation entails a health hazard identification process that involves use o f the following:
• Scientific data on the physicochemical properties o f a chemical
• D ata on hum an exposures and health effects
• Empirical data from in vivo and in vitro laboratory testing
• Com putational techniques, including predictive algorithms and mathematical models that describe a selected process (e.g., skin permeation) by means of ana­lytical or numerical methods.
This Skin Notation Profile provides the SK assignment and supportive data for bisphenol A  (BPA; CAS No. 80-05-7). In  particular, this document evaluates and summarizes the literature describing the substance’s hazard potential and its assessment according to the scientific rationale and framework outlined in CIB 61. In  meeting this objective, this Skin Notation Profile intends to inform the audience— mostly occupational health prac­titioners, researchers, policy- and decision-makers, employers, and workers in potentially hazardous workplaces— so that improved risk-management practices may be developed to better protect workers from the risks of skin contact with the chemical o f interest.
John Howard, M .D.Director, National Institute for Occupational Safety and Health Centers for Disease Control and Prevention
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Abbreviations
A C G IH American Conference o f Governm ental Industrial Hygienists
A TSD R Agency for Toxic Substances and Disease Registry
BPA bisphenol A
CIB Current Intelligence Bulletin
cm2 squared centimeter(s)
cm/hr centimeter(s) per hour
cm/s centimeter(s) per second
DEREK™ Deductive Estim ation o f Risk from Existing Knowledge
D IR skin notation indicating the potential for direct effects to the skin follow­ing contact with a chemical
E C European Commission
G H S Globally Harmonized System of Classification and Labeling o f Chemicals
G P M T guinea pig maximization test
IA R C International Agency for Research on Cancer
IM D S Integrated M odel for the Differentiation o f Skin reactions
(IRR) subnotation o f SK: D IR  indicating the potential for a chemical to be a skin irritant following exposure to the skin
Kaq coefficient in the watery epidermal layer
KP skin permeation coefficient
Kpol coefficient in the protein fraction o f the stratum corneum(IfKpsc permeation coefficient in the lipid fraction o f the stratum corneum
L D 50 dose resulting in 50% mortality in the exposed population
D L o dermal lethal dose
log KOW base-10 logarithm of a substance’s octanol-water partition
M molarity
m3 cubic meter(s)
mg milligram(s)
mg/cm2/h r milligram(s) per square centimeter per hour
mg/kg milligram(s) per kilogram body weightm g/m 3 milligram(s) per cubic meter
mL milliliter(s)
m L/kg milliliter(s) per kilogram body weight
M W molecular weight
N IO S H National Institute for Occupational Safety and Health
N T P National Toxicology Program
O E L occupational exposure limit
vi Skin Notation Profiles Bisphenol A  (BPA)
O SH A Occupational Safety and H ealth Administration
ppm parts per million
REL recommended exposure limit
RF retention factor
SEN skin notation indicating the potential for im m une-m ediated reactions following exposure o f the skin
SI ratio ratio o f skin dose to inhalation dose
SK skin notation
SW solubility
SYS skin notation indicating the potential for systemic toxicity following ex­posure o f the skin
USEPA United States Environmental Protection Agency
hg microgram(s)|ag/mL microgram(s) per milliliter
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Glossary
Absorption—The transport o f a chemical from the outer surface o f the skin into both the skin and systemic circulation (including penetration, permeation, and resorption).
Acute exposure— Contact with a chemical that occurs once or for only a short period o f time.
Cancer—Any one o f a group o f diseases that occurs when cells in the body become abnormal and grow or multiply out o f control.
Contaminant—A  chemical that is (1) unintentionally present w ithin a neat substance or mixture at a concentration less than 1.0% or (2) recognized as a potential carcinogen and present w ithin a neat substance or mixture at a concentration less than 0.1%.
Cutaneous (or percutaneous)— Referring to the skin (or through the skin).
Dermal— Referring to the skin.
Dermal contact— Contact with (touching) the skin.
Direct effects— Localized, non-im m une-m ediated adverse health effects on the skin, including corrosion, primary irritation, changes in skin pigmentation, and reduction/ disruption o f the skin barrier integrity, occurring at or near the point o f contact with chemicals.
Immune-mediated responses— Responses mediated by the immune system, including allergic responses.
Sensitization— A  specific im mune-mediated response that develops following expo­sure to a chemical, which, upon re-exposure, can lead to allergic contact dermatitis (ACD) or other im m une-m ediated diseases such as asthma, depending on the site and route o f re-exposure.
Substance— A  chemical.
Systemic effects— Systemic toxicity associated with skin absorption o f chemicals after exposure o f the skin.
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1 Introduction
1.1 General Substance Information
Chemical: Bisphenol A  (BPA)
CAS No: 80-05-7  
Synonyms:
BPA; 4,4’-(1-M ethylethylidene)bi- sphenol; 4,4’-(propan-2-ylidene)di- phenol; p, p’-isopropylidenebisphe- nol; 4,4'-isopropylidenediphenol; 2,2-bis(4-hydroxyphenyl)propane
Molecular weight (M W ): 228.29
Molecular formula: C 15H 16O 2
Structural formula:
Uses:Bisphenol A  (BPA) is a high- production-volume (H PV ) chemical used in the manufacturing o f epoxy resins, plastics, and flame retardants [N T P -C E R H R  2007].
1.2 Purpose
This Skin Notation Profile presents (1) a brief summary o f technical data associated with skin contact with BPA and (2) the rationale behind the hazard-specific skin notation (SK) assignment for BPA. The SK assignment is based on the scientific rationale and logic outlined in the Current Intelligence Bulletin (CIB) 61: A  Strategy fo r  Assigning New N IO SH  Skin Notations [N IO SH  2009]. The summarized infor­mation and health hazard assessment are limited to an evaluation o f the potential health effects o f dermal exposure to BPA. A  literature search was conducted through July 2010 to identify information on BPA, including but not limited to data relating to its toxicokinetics, acute toxicity, repeat- ed-dose systemic toxicity, carcinogenicity, biological system/function-specific effects (including reproductive and developmen­tal effects and immunotoxicity), irritation, and sensitization. Inform ation was con­sidered from studies o f humans, animals, or appropriate modeling systems that are
relevant to assessing the effects o f dermal exposure to BPA.
1.3 Overview of SK Assignment 
for BPA
BPA is potentially capable o f causing ad­verse health effects following skin contact. A  critical review of available data has re­
sulted in the following SK assignment for BPA: SK: SE N . Table 1 provides an over­view of the critical effects and data used to develop the SK assignment for BPA.
2 Systemic Toxicity from Skin 
Exposure (SK: SYS)
No studies o f BPA in humans or experi­mental animals following dermal exposure 
were identified. M orck et al. [2010] con­ducted a series o f in vitro experiments to evaluate the potential adverse effects of 
BPA exposure during pregnancy. As part of this study, dermal absorption was examined
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Table 1. Summary o f  the SK assignment for BPA
Skin notation Critical Effect(s) Data
SK: SEN Skin allergy; Sufficient human and animal dataphotoallergy
using an in vitro diffusion model that em­ploys full thickness human skin. The au­thors reported that the skin was exposed to 17.5 millimolar BPA for 48 hour in the donor chamber and samples were collected from the receiving chamber at regular time intervals. Among the reported results, 13% of the applied BPA was recovered within 48 hours in the receiving chamber, which represents dermal absorption. Approxi­mately, 7.4% and 17% of the applied dose of BPA were recovered within the epider­mis and dermis, respectively. M orck et al. [2010] concluded that more than 1/3 of the applied dose of BPA was dermally ab­sorbed and may be available systemically. Kaddar et al. [2008] investigated the po­tential for BPA to be percutaneously ab­sorbed through an in vitro diffusion model using pig skin. A  solution o f radiolabelled BPA, 10 micrograms per milliliter (|ag/mL) in physiological serum, was placed on skin samples mounted within modified Franz static diffusion cells. Kaddar et al. [2008] reported that after 2, 5, and 10 hours of exposure, the total BPA skin content was 3%, 6.9%, and 11.4% of the applied dose. After 10 hours, 64,8% of the applied dose remained on the surface o f the skin, 5.4 % of the applied dose was located within the epidermis, and 8.8% of the applied dose was contained within the dermis. Kaddar et al. [2008] concluded that BPA remained pri­marily on the skin surface and the chemical accumulated primarily in the dermis.
No dermal lethal concentration (LDLo) for humans or dermal LD 50 (the dose re­quired to produce mortality in 50% of the exposed population) has been identified
for BPA. The absence o f these data pre­cludes adequate evaluation o f the acute dermal toxicity o f BPA.
No epidemiological studies that evaluated the potential o f BPA to cause systemic effects were identified. A  single study in­vestigating the transfer o f BPA to the skin during the handing o f thermal print­ing paper containing BPA was identified [Beidermann et al. 2010]. The findings of the study demonstrate the contamination o f the skin with BPA, which was highly variable based on the condition o f the skin and exposure scenario. Beidermann et al. [2010] concluded that BPA was trans­ferred to the skin during the handing of the thermal printing paper, but due to the nature o f the study, its ability to penetrate the skin and contribute to systemic dose could not be defined.
No information was available on potential systemic effects in animals following re- peat-dose (21-day or 28-day), subchronic (90-day), or chronic (at least 12-month) dermal exposure to BPA. D uPont [1962] stated that results o f experimental studies and actual experience with BPA elicited no systemic effect from occasional con­tact w ith the chemical; however, details of these studies were not provided.
No standard toxicity or specialty studies evaluating b io logical sy stem /fun c tio n - specific effects (including reproductive and developmental effects and immunotoxic- ity) of BPA following dermal exposures were identified. No epidemiological stud­ies or studies that evaluated the human or animal carcinogenic potential o f BPA
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following dermal exposure were identified. Table 2 provides a summary o f carcino­genic designations from multiple govern­mental and nongovernmental organiza­tions for BPA.
Insufficient data were identified to ad­equately evaluate the potential for dermal uptake o f BPA or its contribution to the onset o f systemic toxic effects in humans or animals following skin contact. There­
fore, on the basis o f the data for this as­sessment, BPA is not assigned the SK: SYS notation.
3 Direct Effects on Skin 
(SK: DIR)
No data on the corrosivity o f BPA from in vitro tests with human or animal skin models or on skin integrity from in vitro tests w ith cadaver skin were identified. However, a limited number o f skin irrita­
tion studies involving animals have been conducted. Shumskaya [1961] evaluated the local effect o f BPA on the skin by ap­plying an unspecified amount o f the pure BPA powder or 10% ointm ent in Vase­line to shaved areas (4 x 4 cm) o f skin on
the backs o f rabbits. O ne application of the pure powder did not produce a pro­nounced skin reaction. However, repeated dermal applications (30 times in 37 days) of the powder caused moderate swelling and redness, which began after the 7th application and lasted for 12 days. After day 15, the skin turned yellow, followed by dark pigmentation. The investigator reported that the skin o f rabbits became dry and began to desquamate and pig­ment 1 week after repeated application of the 10% ointm ent in Vaseline. Shumskaya [1961] concluded, however, that BPA had an insignificant local irritating effect on the skin. D uPont [1962] observed only a very slight, simple irritation on the skin of rabbits following continuous contact with the dry powder under a bandage, over a 2-week period. In  this study, three similar applications o f dry powder to abraded skin produced practically no irritation, whereas application o f a 10% aqueous solution un­der occlusion was slightly irritating to the rabbits. Thorgeirsson and Fregert [1977] observed no irritation to guinea pig skin following a 24-hour occlusive exposure in acetone. In  a more recent study, Vohr et al. [2004] found no irritating potential for BPA when they exposed mice to BPA up
Table 2. Summary o f the carcinogenic designations* for BPA by numerous 
governmental and nongovernmental organizations
Organization Carcinogenic designation
NIOSH [2005] None
NTP [2009] None
USEPA [2009] None
IARC [2009] None
EC [2010] None
ACGIH None
A bbreviations: A C G IH  = A m erican  C onference o f G overnm ental Industria l Hygienists; E C  = E uropean  C om m ission , Jo in t 
Research, Institu te  for H ealth  and C onsum er Protection; IA R C  = In te rna tiona l A gency for R esearch on C ancer; N IO S H  = 
N ational Institu te  for O ccupational Safety and H ealth ; N T P  = N ational Toxicology Program ; U S E P A  = U nited  States E nviron­
m ental P rotection A gency.
*Note: The listed cancer designations were based on data  from  nonderm al (such as oral or inhalation) exposure ra ther than  
derm al exposure.
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to its solubility lim it (reported as 30%); the investigators used a modified local lymph node assay (LLNA) and the Integrated M odel for the Differentiation o f Skin re­actions (IM DS). No predictions from the structure-activity relationship model, D e­ductive Estim ation o f Risk from Existing Knowledge (DEREK™ ) for W indows, were available for BPA. Hulzebos and Gerner [2010] evaluated the potential of BPA to act as a skin irritant using the In ­tegrated Assessment Scheme (IAS). This evaluation tool is designed to critically as­sess multiple lines o f toxicological data to determine the potential o f a substance to cause skin irritation. Hulzebos and G ern- er [2010] predicted that BPA is not a skin corrosive or irritant based on the results of the IAS analysis.
Taken together, the results o f the reviewed study indicate that BPA has limited or no potential o f causing direct effects of the skin, including corrosion or irritation. Therefore, on the basis o f the data for this assessment, BPA is not assigned the SK: D IR  notation.
4 Immune-mediated 
Responses(SK: SEN)
Several cases were identified in which pa­tients presented with contact dermatitis or skin lesions. Diagnostic patch-tests with 1% BPA revealed that these patients were allergic to BPA [Romaguera et al. 1981, 1986; Freeman and W arin 1984; Van Joost et al. 1988, 1990; Srinivas et al. 1989]. Sev­eral workers, patients, or volunteers with or w ithout dermatitis have also been patch- tested to evaluate the potential o f BPA to cause skin sensitization or photoallerge- nicity. Standard patch-testing o f some of these subjects with 1% or 2% BPA pro­duced allergic reactions in some [ Jolanki et al. 1990], but not in others [Freeman and
W arin 1984; Prens et al. 1986; Van Joost 1988; Van Joost et al. 1990]. No cross­reactivity was reported between BPA and epichlorohydrin when patients with con­firmed allergic contact dermatitis due to epichlorohydrin were tested [Van Joost et al. 1988]. It should be noted that posi­tive results noted in these studies may be caused by cross-reactivity with BPA resins.
O ne study evaluated the skin sensitiza­tion potential o f BPA. In  this study, Thor- geirsson and Fregert [1977] observed no skin sensitization reaction in a guinea pig maximization test (G PM T ) when animals were induced with a 5% solution o f BPA in acetone, followed by a challenge with a 1% solution. These investigators found no cross-reactions between BPA and its diglycidyl ether-BPA-based epoxy res­ins and epichlorohydrin. Several studies have also evaluated the photoallergenicity o f BPA in predictive animal models. For example, Gerberick and Ryan [1990] con­firmed that BPA is a photoallergen in the mouse ear-swelling test. Vohr et al. [2004] investigated the sensitizing or photoaller- genic potential o f BPA with a modified murine local lymph node assay, the IM DS, to distinguish skin sensitization from acute irritation. Those investigators also used a U V -IM D S assay to test for photoreactivity o f BPA. In  their study, dermal application o f 3%, 10%, or 30% (solubility limit) BPA to mice did not result in any skin sensiti­zation. UV irradiation o f mice after each application did not result in photoallergic reactions. O n  the basis of these results, Vohr et al. [2004] did not consider BPA to be a skin sensitizer or photosensitizer. DEREK™  predicted BPA to be positive for skin sensitization.
Inform ation available from human experi­ence [Romaguera et al. 1981, 1986; Free­man and Warin 1984; Van Joost 1988; 
Srinivas et al. 1989; Jolanki et al. 1990;
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Table 3. Summary o f the previously issued skin hazard designations for BPA
Organization Skin hazard designation
NIOSH [2005] None
OSHA None
ACGIH [2005] None
EC [2010] R43: May cause sensitization by skin contact
A bbreviations: A C G IH  = A m erican  C onference o f G overnm ental Industria l Hygienists; E C  = E uropean  C om m ission , Jo in t 
Research, Institu te  for H ealth  and C onsum er Protection; N IO S H  = N ational Institu te  for O ccupational Safety and H ealth ; 
O S H A  = O ccupational Safety and H ealth  A dm inistration .
Van Joost et al. 1990*] and a predictive test in animals (mouse ear-swelling test) 
[Gerberick and Ryan 1990] is sufficient to conclude that BPA is a skin sensitizer and photoallergen. Therefore, on the basis o f the data for this assessment, BPA is as­signed the SK: SEN  notation.
5 Summary
Lack o f relevant toxicokinetic and toxicity data on BPA precludes adequate evalua­tion of the potential o f the chemical to be absorbed through the skin and to cause systemic effects in humans or animals fol­lowing dermal exposure. In  vitro studies indicate that BPA may be readily absorbed by the skin [Kaddar et al. 2008; M orck et al. 2010]. Review of available animal stud­ies and predictive tools indicate that BPA has limited or no potential to cause direct effects o f the skin including corrosion and irritation. The skin sensitization poten­tial o f the chemical has been evaluated in several case reports and predictive ani­mal studies (mouse ear-swelling test). The weight of evidence indicates that BPA is a skin sensitizer and can cause photoallergy 
[Romaguera et al. 1981, 1986; Freeman and Warin 1984; Van Joost 1988; Srini- 
vas et al. 1989; Gerberick and Ryan 1990;
References in bold text indicate studies that served as the basis of the SK assignment.
Jolanki et al. 1990; Van Joost et al. 1990].Therefore, on the basis o f this assessment, BPA is assigned a composite skin notation o f SK: SE N .
Table 3 summarizes the skin hazard des­ignations for BPA previously issued by N IO S H  and other organizations. The equivalent dermal designation for BPA, according to the Globally Harm onized System (G H S) o f Classification and La­beling o f Chemicals, is Skin Sensitization Category 1 (Hazard statement: M ay cause an allergic skin reaction) [European Par­liament 2008]. BPA has been identified as a Category 2 Reproductive toxicant (H az­ard statement: Suspected o f damaging fer­tility) [European Parliament 2008].
References
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